Health-related quality of life and work productivity associated with HiSCR and NRS30 response among patients with moderate to severe hidradenitis suppurativa

        Objective: Skin pain in patients with hidradenitis suppurativa (HS) is an important and potentially debilitating symptom impairing patients’ health-related quality of life (HRQL). This study quantified HRQL and work productivity benefit associated with lesion control (ie, Hidradenitis Suppurativa Clinical Response, HiSCR – a ≥50% reduction in inflammatory lesion count, and no increase in abscess or draining fistula) and skin pain control (ie, NRS30 – at least 30% reduction on a numerical rating scale between 0 and 10).
        To read this article in full you will need to make a payment
        AAD Member Login
        AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
        Already a print subscriber? Claim online access
        Already an online subscriber? Sign in
        Institutional Access: Sign in to ScienceDirect